MS Newbies: Recently Approved and Pipeline Drugs for the Treatment of Multiple Sclerosis Webcast

MS Newbies: Recently Approved and Pipeline Drugs for the Treatment of Multiple Sclerosis Webcast is organized by AchieveCE.

Activity Release Date: November 23, 2021
Activity Expiration Date: November 23, 2024

Activity Overview:
The field of Multiple Sclerosis is ever-changing, with new targets and biomarkers being discovered each year. It can be challenging to stay up to date on newly approved agents given so many different components that play a role in the treatment of Multiple Sclerosis.

This activity will review the newest FDA-approved Multiple Sclerosis treatment agents including efficacy and safety features. This activity will also provide clinicians with drug/patient characteristics that are critical for appropriate treatment selection and recommendations.

Pharmacist Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:
• Discuss the mechanism of action of newly approved MS treatments
• Discuss the mechanism of action of pipeline multiple sclerosis treatments
• Discuss literature to date for approval of new agents and pending trials for pipeline MS treatments

Pharmacy Technician Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:
• Review the mechanism of action of newly approved MS treatments
• Review how pipeline multiple sclerosis treatments work
• Discuss literature to date for approval of new agents and pending trials for pipeline MS treatments

Nurse Learning Objectives:
At the conclusion of this continuing education activity, the participant will be able to:
• Review the mechanism of action of newly approved MS treatments
• Review how pipeline multiple sclerosis treatments work
• Discuss literature to date for approval of new agents and pending trials for pipeline MS treatments.